GTC Biotherapeutics (fka GTCB)

[DragonBits]

winvestor2, I believe this article on follow-on biologics addresses the issues that confront GTC in connection with producing generic biologics.

http://www.buildingipvalue.com/05_NA/135_138.htm

MNTA is another company you might want to look into, and as I said, Dew is a good resource to whom you should address these sorts of questions, as I have no opinion on these aspects of the industry.

MNTA feels that follow-on biologics legislation will be passed in either 2009 or 2010.

Another thought is that when companies like Abbott and Bristol-Myers Squibb engaged GTC to create founder animals, does this preclude someone like Teva from contracting with GTC to produce the drugs these companies contracted for even if the patent expires. I don't know if this is significant or not.